GCG and type 2 diabetes mellitus: Finally, it has been demonstrated that obese T2D patients treated with exenatide for 12 weeks show significantly increased irisin levels, and this increase is correlated with an improvement in the metabolic profile [59], thus suggesting the existence of a possible interplay between irisin and incretin hormones.